✦ Where quality meets affordability · Biomed-tested · Certified

J&J data show lower mortality with Impella in HRPCI than CHIP-BCIS3

J&J data show lower mortality with Impella in HRPCI than CHIP-BCIS3
Summary

J&J presented three clinical analyses at TCT 2026 showing lower mortality with Impella heart pump support in HRPCI patients.

The post J&J data show lower mortality with Impella in HRPCI than CHIP-BCIS3 appeared first on Medical Device Network.

Read the full article ↗Looking to buy or rent? Get a quote

More from Medical Device Network

Dexcom lifts 2026 revenue outlook after positive Q3Omron Healthcare begins production at first India plantAbbott’s paravalvular leak treatment secures FDA approvalBaxter’s shares fall as Q3 probability dips despite revenue growth